Location History:
- Bronx, NY (US) (2000 - 2011)
- New York, NY (US) (2013)
Company Filing History:
2 out of 504 
1 out of 1,390 
1 out of 832,891 Years Active: 2000-2013
Title: Innovations and Contributions of Inventor Tsungda Hsu
Introduction
Tsungda Hsu is a notable inventor based in the Bronx, NY (US). He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 4 patents, Hsu's work focuses on mycobacterial mutants and their applications in vaccine development.
Latest Patents
Hsu's latest patents include groundbreaking work on mycobacterial mutants that induce IL-12. These patents provide mycobacteria that are deleted in at least a portion of a region 3 ESAT-6-like gene cluster. Additionally, they include mycobacteria with mutations in an roc-1 gene. His patents also cover vaccines that utilize these mycobacteria, along with methods for making recombinant forms, inducing immune responses in mammals, and stimulating or inhibiting IL-12 production. Furthermore, he has developed methods for treating mammals deficient in CD4 and/or CD8 lymphocytes using attenuated mycobacteria.
Career Highlights
Throughout his career, Tsungda Hsu has worked with esteemed institutions such as the Albert Einstein College of Medicine and the Iowa State University Research Foundation, Inc. His research has significantly advanced the understanding of mycobacterial infections and their treatment.
Collaborations
Hsu has collaborated with prominent figures in the field, including William R. Jacobs, Jr. and Stoyan S. Bardarov. These collaborations have further enriched his research and contributions to immunology.
Conclusion
Tsungda Hsu's innovative work in the field of immunology, particularly through his patents on mycobacterial mutants, showcases his dedication to advancing medical science. His contributions have the potential to impact vaccine development and treatment strategies for immunocompromised individuals.